Identificação e validação de epítopos potencialmente antigênicos de Babesia bovis por abordagens de vacinologia reversa, genética molecular e imunologia experimental
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
DOI
Abstract
Bovine Parasitic Sadness (BPS) is a complex of hemoparasitic diseases caused by
Babesia bovis, Babesia bigemina, and Anaplasma marginale, with B. bovis being the
agent associated with the most severe clinical manifestations of BPS. Its control
involves management of the tick vector, chemoprophylaxis, and the use of live
vaccines, strategies that present limitations related to acaricide resistance,
maintenance of enzootic stability, and the risks and practical difficulties associated with
the use of viable infectious agents. In this context, the development of vaccines based
on defined antigens represents a promising alternative, and reverse vaccinology,
integrated with bioinformatics and immunoinformatics tools, enables the identification
and rational prioritization of candidates based on genomic information. Therefore, this
study aimed to identify and evaluate candidate epitopes of B. bovis through the
integration of reverse vaccinology, molecular genetics, and experimental immunology.
Initially, the predicted proteome derived from the reference genome of the B. bovis
T2Bo strain, comprising 3,959 protein-coding genes, was analyzed in silico, and
application of the selection criteria allowed the prioritization of nine plasma membrane
proteins with VaxiJen antigenicity scores above 0.7, from which 31 candidate epitopes
were predicted. The gene regions corresponding to the selected candidates were
evaluated in Brazilian B. bovis isolates by PCR, sequencing, and alignment analysis.
High conservation was observed in the analyzed regions of the BBOV_IV000770 gene,
which encodes the predicted protein XP_001609243.1 and contains five of the
selected epitopes. Based on this validation, the peptides CNPGL-Bbovis-5E2,
CNPGL-Bbovis-5E3, and CNPGL-Bbovis-5E5 were synthesized, initially conjugated
to the carrier protein KLH. The conjugated peptides were evaluated for
immunoreactivity by indirect ELISA using sera from cattle experimentally infected with
B. bovis, and for their effects on the metabolic activity of peripheral blood mononuclear
cells (PBMCs) using cells obtained from animals previously exposed to natural B. bovis
infection. The peptides were also evaluated in their free form using ELISA and the
resazurin reduction assay. The peptides conjugated to the carrier protein KLH showed
no IgG recognition attributable to the peptides and did not consistently differ from KLH
alone in terms of PBMC metabolic activity. In their free form, the peptides CNPGLBbovis-5E3 and CNPGL-Bbovis-5E5 showed serological IgG recognition in a subset
of B. bovis-positive animals, with heterogeneity among samples, while the three
peptides exhibited distinct profiles of modulation of PBMC metabolic activity. CNPGL-
Bbovis-5E3 stood out by showing effects associated with peptide concentration and
incubation time. Overall, the results enabled the prioritization of B. bovis candidates
based on evidence of conservation, serological recognition, and functional activity,
highlighting CNPGL-Bbovis-5E3 as a promising antigenic candidate. Further studies
specifically addressing immunogenicity and protection are required to determine its
vaccine potential and, additionally, to assess the applicability of these candidates in
immunodiagnostic strategies.
Description
Keywords
Citation
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

